GRAVES GREGORY B
SEC CIK 1208109 · EDGAR
BoughtSold
Most active insiders at LSF, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LaMontagne Grant J | Dir | $298.4K | — |
| 2 | GRAVES GREGORY B | Dir | $51.8K | — |
| 3 | Hamill Anna | CFO | — | — |
| 4 | Vieth Jason D. | CEO, Dir | — | — |
| 5 | Hamilton Laird | Chief Innovator, Dir | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 17:59 | 2026-06-10 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | P - Purchase | $3.45 | +15.0K | 75.1K | +25% | +$51.8K | |
| M | 2026-05-20 17:05 | 2026-05-19 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | S - Sale | $141.61 | -3,225 | 5,473 | -37% | -$456.7K |
| 2026-05-18 17:05 | 2026-05-15 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +1,440 | 8,698 | +20% | $0 | |
| 2025-06-30 | 2025-06-26 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | A - Grant | $6.31 | +8,716 | 60.1K | +17% | +$55.0K | |
| 2025-05-28 | 2025-05-23 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | G - Gift | $0.00 | -28.5K | 51.4K | -36% | $0 | |
| 2025-05-28 | 2025-05-23 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | S - Sale | $7.03 | -2,127 | 79.9K | -3% | -$15.0K | |
| 2025-05-15 | 2025-05-15 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +3,586 | 7,258 | +98% | $0 | |
| 2024-11-19 | 2024-11-15 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | G - Gift | $0.00 | -18.0K | 82.0K | -18% | $0 | |
| 2024-06-28 | 2024-06-27 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +20.0K | 100.0K | +25% | $0 | |
| A | 2024-05-16 | 2024-05-15 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +1,662 | 3,672 | +83% | $0 |
| 2024-05-15 | 2024-05-14 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | A - Grant | $2.68 | +8,099 | 80.0K | +11% | +$21.7K | |
| 2024-05-15 | 2024-05-15 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +1,162 | 3,172 | +58% | $0 | |
| M | 2024-03-15 | 2024-03-15 | ACLS | AXCELIS TECHNOLOGIES INC | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +2,010 | 1,340 | New | $0 |
| 2023-05-08 | 2023-05-04 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +40.0K | 71.9K | +125% | $0 | |
| M | 2023-02-23 | 2023-02-21 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | S - Sale | $82.19 | -8,073 | 20.7K | -28% | -$663.5K |
| 2023-02-21 | 2023-02-17 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | F - Tax | $85.48 | -6,156 | 27.8K | -18% | -$526.2K | |
| M | 2023-02-15 | 2023-02-14 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | S - Sale | $83.72 | -3,691 | 36.6K | -9% | -$309.0K |
| 2023-02-15 | 2023-02-13 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | A - Grant | $0.00 | +5,491 | 39.4K | +16% | $0 | |
| 2023-02-15 | 2023-02-13 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | F - Tax | $84.94 | -1,800 | 37.6K | -5% | -$152.9K | |
| D | 2023-02-02 | 2023-01-31 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | A - Grant | $0.00 | +13.0K | 33.9K | +62% | $0 |
| 2022-05-09 | 2022-05-05 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | A - Grant | $0.00 | +14.0K | 31.9K | +78% | $0 | |
| D | 2022-04-01 | 2022-03-31 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | M - OptEx | $55.72 | +12.1K | 33.1K | +58% | +$676.6K |
| DM | 2022-04-01 | 2022-03-31 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | S - Sale+OE | $133.10 | -12.1K | 21.3K | -36% | -$1.62M |
| 2022-03-17 | 2022-03-15 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | P - Purchase | $3.00 | +15.0K | 17.9K | +517% | +$45.0K | |
| DM | 2022-02-24 | 2022-02-22 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | S - Sale+OE | $127.88 | -31.3K | 21.0K | -60% | -$4.01M |
| DM | 2022-02-24 | 2022-02-22 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | M - OptEx | $32.21 | +20.3K | 42.2K | +93% | +$654.8K |
| 2022-02-23 | 2022-02-18 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | F - Tax | $130.19 | -4,764 | 32.0K | -13% | -$620.2K | |
| 2022-02-15 | 2022-02-11 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | F - Tax | $124.48 | -3,583 | 36.8K | -9% | -$446.0K | |
| 2022-02-15 | 2022-02-11 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | A - Grant | $0.00 | +8,450 | 40.3K | +27% | $0 | |
| MA | 2022-02-11 | 2021-10-04 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | S - Sale | $17.55 | -1,964 | 3,001 | -40% | -$34.5K |
| D | 2022-02-03 | 2022-02-01 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | A - Grant | $0.00 | +6,540 | 31.9K | +26% | $0 |
| M | 2021-10-06 | 2021-10-04 | LSF | Laird Superfood, Inc. | GRAVES GREGORY B | Dir | S - Sale | $17.55 | -1,964 | 25.9K | -7% | -$34.5K |
| 2021-08-24 | 2021-08-20 | ENTG | ENTEGRIS INC | GRAVES GREGORY B | EVP, CFO | S - Sale | $112.41 | -4,500 | 25.3K | -15% | -$505.8K |
Purchase Sale Sale after option exercise All abbreviations